US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
IL89489A0
(en)
|
1988-03-09 |
1989-09-10 |
Hybritech Inc |
Chimeric antibodies directed against human carcinoembryonic antigen
|
US5169836A
(en)
|
1988-11-10 |
1992-12-08 |
Trustees Of The University Of Penna. |
Inhibitors of platelet binding
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
US6916605B1
(en)
|
1990-07-10 |
2005-07-12 |
Medical Research Council |
Methods for producing members of specific binding pairs
|
GB9108652D0
(en)
|
1991-04-23 |
1991-06-12 |
Antisoma Ltd |
Immunoreactive compounds
|
US5843749A
(en)
|
1991-07-26 |
1998-12-01 |
Regeneron Pharmaceuticals, Inc. |
Ehk and Ror tyrosine kinases
|
ATE175997T1
(de)
|
1991-08-10 |
1999-02-15 |
Medical Res Council |
Behandlung von zellpopulationen
|
US5830470A
(en)
|
1992-09-07 |
1998-11-03 |
Kyowa Hakko Kogyo Co., Ltd. |
Humanized antibodies to ganglioside GM2
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
JP3095175B2
(ja)
|
1992-11-13 |
2000-10-03 |
アイデック ファーマシューティカルズ コーポレイション |
B細胞リンパ腫の治療のためのヒトbリンパ球限定分化抗原に対するキメラ抗体と放射能標識抗体の療法利用
|
GB9325182D0
(en)
|
1993-12-08 |
1994-02-09 |
T Cell Sciences Inc |
Humanized antibodies or binding proteins thereof specific for t cell subpopulations exhibiting select beta chain variable regions
|
US6309636B1
(en)
|
1995-09-14 |
2001-10-30 |
Cancer Research Institute Of Contra Costa |
Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
|
US5783184A
(en)
|
1994-12-23 |
1998-07-21 |
Smithkline Beecham Corporation |
Method for treatment and diagnosis of IL-5 mediated disorders
|
US5977316A
(en)
|
1995-01-17 |
1999-11-02 |
The Board Of Trustees Of The University Of Kentucky |
Monoclonal antibody 1A7 and related polypeptides
|
WO1996036361A1
(en)
|
1995-05-18 |
1996-11-21 |
The Regents Of The University Of Michigan |
Dna binding antibodies
|
ATE208403T1
(de)
|
1995-05-26 |
2001-11-15 |
Merck Patent Gmbh |
Antiidiotypische antikörper die eine immunantwort gegen den rezeptor für epidermalen wachstumsfaktor induzieren
|
ATE395422T1
(de)
|
1995-06-07 |
2008-05-15 |
Sanofi Pasteur Ltd |
Chimäre antikörper zur abgabe von antigenen an selektierte zellen des immunsystems
|
US6410690B1
(en)
|
1995-06-07 |
2002-06-25 |
Medarex, Inc. |
Therapeutic compounds comprised of anti-Fc receptor antibodies
|
EP0918858A1
(en)
|
1996-05-10 |
1999-06-02 |
Biogen, Inc. |
Common gamma chain blocking agents
|
EP0938506B1
(en)
|
1996-07-16 |
2003-11-05 |
Plückthun, Andreas, Prof. Dr. |
Immunoglobulin superfamily domains and fragments with increased solubility
|
US6800744B1
(en)
|
1997-07-02 |
2004-10-05 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
|
PT1032674E
(pt)
|
1997-11-21 |
2007-03-30 |
Serono Genetics Inst Sa |
Sequência genómica e polipéptidos (de chlamydia pneumoniae), seus fragmentos e suas utilizações, em particular para o diagnóstico, prevenção e tratamento de infacção
|
US7041490B1
(en)
|
1997-11-28 |
2006-05-09 |
Serono Genetics Institute, S.A. |
Chlamydia trachomatis polynucleotides and vectors, recombinant host cells, DNA chips or kits containing the same
|
US6562958B1
(en)
|
1998-06-09 |
2003-05-13 |
Genome Therapeutics Corporation |
Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics
|
TR200100705T2
(tr)
|
1998-06-26 |
2001-10-22 |
Iowa State University Research Foundation, Inc. |
Bitkilerde enzim ve asetil'in değiştirilmesi için yöntemler.
|
WO2000023593A2
(en)
|
1998-10-16 |
2000-04-27 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Molecular pathogenicide mediated plant disease resistance
|
US6822071B1
(en)
|
1998-11-12 |
2004-11-23 |
The Regents Of The University Of California |
Polypeptides from Chlamydia pneumoniae and their use in the diagnosis, prevention and treatment of disease
|
US7297341B1
(en)
|
1998-12-23 |
2007-11-20 |
Sanofi Pasteur Limited |
Chlamydia antigens and corresponding DNA fragments and uses thereof
|
US6897044B1
(en)
|
1999-01-28 |
2005-05-24 |
Biogen Idec, Inc. |
Production of tetravalent antibodies
|
JP2003525024A
(ja)
|
1999-03-11 |
2003-08-26 |
ジェネシス リサーチ アンド デベロップメント コーポレイション リミテッド |
遺伝子転写改変のための組成物と方法
|
US6703491B1
(en)
|
1999-03-17 |
2004-03-09 |
Exelixis, Inc. |
Drosophila sequences
|
US6753314B1
(en)
|
1999-04-01 |
2004-06-22 |
Curagen Corporation |
Protein-protein complexes and methods of using same
|
WO2000062071A1
(de)
|
1999-04-13 |
2000-10-19 |
Wilex Ag |
Diagnostischer und therapeutischer einsatz von antikörpern gegen den urokinase-rezeptor
|
US20060242729A1
(en)
|
1999-07-30 |
2006-10-26 |
Cahoon Edgar B |
Polynucleotides encoding proteins involved in plant metabolism
|
GB9918788D0
(en)
|
1999-08-10 |
1999-10-13 |
Leuven K U Res & Dev |
Antithrombotic effect of platelet glycoprotein 1b blocking monoclonal Fab fragments
|
DE19946142A1
(de)
|
1999-09-27 |
2001-03-29 |
Bundesrepublik Deutschland Let |
Gentransfer in humane Lymphocyten mittels retroviraler scFv-Zelltargeting Vektoren
|
US20020034784A1
(en)
|
1999-10-27 |
2002-03-21 |
John Bertin |
Novel molecules of the card-related protein family and uses thereof
|
US7034121B2
(en)
|
2000-01-27 |
2006-04-25 |
Genetics Institue, Llc |
Antibodies against CTLA4
|
US20030235584A1
(en)
|
2000-02-28 |
2003-12-25 |
Kloetzer William S. |
Method for preparing anti-MIF antibodies
|
US20030092091A1
(en)
|
2000-03-07 |
2003-05-15 |
Abrahamson Julie A. |
Sialoadhesin factor-2 antibodies
|
US6833447B1
(en)
|
2000-07-10 |
2004-12-21 |
Monsanto Technology, Llc |
Myxococcus xanthus genome sequences and uses thereof
|
US6812339B1
(en)
|
2000-09-08 |
2004-11-02 |
Applera Corporation |
Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
|
JP4254931B1
(ja)
|
2000-10-27 |
2009-04-15 |
カイロン ソチエタ ア レスポンサビリタ リミタータ |
A群連鎖球菌およびb群連鎖球菌由来の核酸およびタンパク質
|
US7105348B2
(en)
|
2000-10-31 |
2006-09-12 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US20050144655A1
(en)
|
2000-10-31 |
2005-06-30 |
Economides Aris N. |
Methods of modifying eukaryotic cells
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US6586251B2
(en)
|
2000-10-31 |
2003-07-01 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
US7408041B2
(en)
|
2000-12-08 |
2008-08-05 |
Alexion Pharmaceuticals, Inc. |
Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereof
|
EP1392859B1
(en)
|
2001-01-16 |
2006-05-10 |
Regeneron Pharmaceuticals, Inc. |
Isolating cells expressing secreted proteins
|
US20140072979A1
(en)
|
2001-01-16 |
2014-03-13 |
Regeneron Pharmaceuticals, Inc. |
Isolating cells expressing secreted proteins
|
US20140072980A1
(en)
|
2001-01-16 |
2014-03-13 |
Regeneron Pharmaceuticals, Inc. |
Isolating cells expressing secreted proteins
|
US20090137416A1
(en)
|
2001-01-16 |
2009-05-28 |
Regeneron Pharmaceuticals, Inc. |
Isolating Cells Expressing Secreted Proteins
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
KR20030071861A
(ko)
|
2001-01-26 |
2003-09-06 |
인히비텍스, 인코포레이티드 |
Clfa 단백질에 대한 단일 클론성 항체 및 감염의 치료또는 예방에 있어서의 사용 방법
|
WO2002096948A2
(en)
|
2001-01-29 |
2002-12-05 |
Idec Pharmaceuticals Corporation |
Engineered tetravalent antibodies and methods of use
|
WO2002074903A2
(en)
|
2001-02-22 |
2002-09-26 |
Institut Pasteur |
Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses
|
EP1539233B1
(en)
|
2001-07-12 |
2011-04-27 |
FOOTE, Jefferson |
Super humanized antibodies
|
US7282336B2
(en)
|
2001-07-18 |
2007-10-16 |
Bionomics Limited |
Method of diagnosing epilepsy
|
KR100464926B1
(ko)
|
2001-09-14 |
2005-01-05 |
한국과학기술연구원 |
HIV-1 gp41의 N-말단에 특이적으로 결합하는 항체
|
US7361478B2
(en)
|
2001-11-20 |
2008-04-22 |
Allergan, Inc. |
High-throughput screen for identifying selective persistent sodium channels channel blockers
|
CN100522999C
(zh)
|
2002-02-14 |
2009-08-05 |
免疫医疗公司 |
抗cd20抗体及其融合蛋白和使用方法
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
AU2003222664A1
(en)
|
2002-04-18 |
2003-11-03 |
Genencor International, Inc. |
Production of functional antibodies in filamentous fungi
|
GB0210783D0
(en)
|
2002-05-10 |
2002-06-19 |
Polonelli Luciano |
Anti-microbial polypeptides
|
US7232888B2
(en)
|
2002-07-01 |
2007-06-19 |
Massachusetts Institute Of Technology |
Antibodies against tumor surface antigens
|
US7820166B2
(en)
|
2002-10-11 |
2010-10-26 |
Micromet Ag |
Potent T cell modulating molecules
|
US7959915B2
(en)
|
2003-03-12 |
2011-06-14 |
Tufts University |
Inhibitors of extracellular Hsp90
|
US8394379B2
(en)
|
2003-05-15 |
2013-03-12 |
Iogenetics, Llc |
Targeted cryptosporidium biocides
|
CA2434668A1
(en)
|
2003-07-04 |
2005-01-04 |
Laurence Mulard |
Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a
|
US7754209B2
(en)
|
2003-07-26 |
2010-07-13 |
Trubion Pharmaceuticals |
Binding constructs and methods for use thereof
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
US8344211B2
(en)
|
2008-08-13 |
2013-01-01 |
Ceres, Inc. |
Plant nucleotide sequences and corresponding polypeptides
|
US7205450B2
(en)
|
2003-10-08 |
2007-04-17 |
The Regents Of The University Of California |
DMI1 gene encodes a protein that is required for the early steps of bacterial and fungal symbioses
|
PE20090046A1
(es)
|
2003-11-10 |
2009-01-26 |
Schering Corp |
Anticuerpo recombinante humanizado anti-interleuquina 10
|
DE10353593A1
(de)
|
2003-11-17 |
2005-06-23 |
Klinikum der Universität München Großhadern-Innenstadt |
Leptinantagonist und Verfahren zur quantitativen Messung von Leptin
|
KR20130041373A
(ko)
|
2003-12-23 |
2013-04-24 |
제넨테크, 인크. |
신규 항-il13 항체 및 그 용도
|
US8298532B2
(en)
|
2004-01-16 |
2012-10-30 |
Regeneron Pharmaceuticals, Inc. |
Fusion polypeptides capable of activating receptors
|
DE602005027309D1
(de)
|
2004-01-16 |
2011-05-19 |
Regeneron Pharma |
Zur aktivierung von rezeptoren fähige fusionspolypeptide
|
US7608700B2
(en)
|
2004-03-08 |
2009-10-27 |
North Carolina State University |
Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor
|
MXPA06011538A
(es)
|
2004-04-06 |
2007-01-26 |
Univ California |
Tirosina cinasa de receptor huerfano como un objetivo en cancer de mama.
|
GB0410627D0
(en)
|
2004-05-12 |
2004-06-16 |
Scancell Ltd |
Specific binding members
|
RU2006145905A
(ru)
|
2004-05-25 |
2008-06-27 |
ЭТТЕНЬЮОН, ЭлЭлСи (US) |
Лиганды, связывающие комплекс активатора плазминогена урокиназного типа (upa) и его рецептора (upar), которые ингибируют последующие взаимодействия upar: идентификация и использование в диагностике или терапии
|
US7629444B1
(en)
|
2004-06-15 |
2009-12-08 |
Monsanto Technology Llc |
Nucleotide and amino acid sequences from Xenorhabdus bovienii strain Xs85831 and uses thereof
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
BR122018016031B8
(pt)
|
2004-08-04 |
2021-07-27 |
Applied Molecular Evolution Inc |
processo para produzir um anticorpo monoclonal variante com resposta de adcc realçada
|
US7319142B1
(en)
|
2004-08-31 |
2008-01-15 |
Monsanto Technology Llc |
Nucleotide and amino acid sequences from Xenorhabdus and uses thereof
|
US7435804B2
(en)
|
2004-10-19 |
2008-10-14 |
Phage Biotechnology, Inc. |
Method for obtaining single chain antibodies to human interferon α2b
|
GB0425569D0
(en)
|
2004-11-19 |
2004-12-22 |
Celltech R&D Ltd |
Biological products
|
ATE531733T1
(de)
|
2005-01-06 |
2011-11-15 |
Novo Nordisk As |
Kir-bindende wirkstoffe und verfahren zu ihrer verwendung
|
AU2006219823A1
(en)
|
2005-03-02 |
2006-09-08 |
Metanomics Gmbh |
Process for the production of fine chemicals
|
EP1856291A4
(en)
|
2005-03-04 |
2009-04-01 |
Verenium Corp |
NUCLEIC ACIDS AND PROTEINS, AND METHODS OF MAKING AND USING SAME
|
CN101237890A
(zh)
|
2005-06-10 |
2008-08-06 |
中外制药株式会社 |
含有葡甲胺的蛋白质制剂的稳定剂及其利用
|
US20110088126A1
(en)
|
2005-06-17 |
2011-04-14 |
Arborgen, Llc |
Cell signaling genes and related methods
|
BRPI0613770A2
(pt)
|
2005-07-22 |
2009-05-19 |
Y S Therapeutics Co Ltd |
anticorpos anti-cd26 e métodos de uso destes
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
GB0520436D0
(en)
|
2005-10-07 |
2005-11-16 |
Photobiotics Ltd |
Biological materials and uses thereof
|
WO2008103849A2
(en)
|
2007-02-21 |
2008-08-28 |
The Regents Of The University Of California |
Methods and compounds for lymphoma cell detection and isolation
|
WO2007051077A2
(en)
|
2005-10-28 |
2007-05-03 |
The Regents Of The University Of California |
Methods and compounds for lymphoma cell detection and isolation
|
EA016245B9
(ru)
|
2005-11-18 |
2013-04-30 |
Гленмарк Фармасеутикалс С.А. |
Антитела против альфа2-интегрина и их применение
|
EP1957541A2
(en)
|
2005-11-21 |
2008-08-20 |
Laboratoires Serono SA |
Compositions and methods of producing hybrid antigen binding molecules and uses thereof
|
EP1790664A1
(en)
|
2005-11-24 |
2007-05-30 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against claudin-18 for treatment of cancer
|
AU2006319358B2
(en)
|
2005-11-30 |
2012-01-19 |
AbbVie Deutschland GmbH & Co. KG |
Anti-Abeta globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
|
CN101370827B
(zh)
|
2005-12-21 |
2015-10-14 |
麦克罗梅特股份公司 |
具有cea抗性的药物组合物
|
CN103690947A
(zh)
|
2006-01-12 |
2014-04-02 |
阿莱克申药物公司 |
抗ox-2/cd200的抗体及其用途
|
EP2730587A3
(en)
|
2006-02-09 |
2014-08-27 |
Pioneer Hi-Bred International, Inc. |
Genes for enhancing nitrogen utilization efficiency in crop plants
|
BRPI0707626A2
(pt)
|
2006-02-10 |
2011-05-10 |
Monsanto Technology Llc |
identificaÇço e uso de genes alvos para o controle de nematàides parasitas de plantas
|
EP1998799B8
(en)
|
2006-03-06 |
2014-03-05 |
Medlmmune, LLC |
Humanized anti-cd22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
WO2007109742A2
(en)
|
2006-03-21 |
2007-09-27 |
Weaver David T |
Methods for humanizing antibodies and humanized antibodies made thereby
|
RU2008134135A
(ru)
|
2006-03-21 |
2010-04-27 |
Вайет (Us) |
Соединения-антагонисты белка rage и способы их применения
|
NZ567888A
(en)
|
2006-03-23 |
2010-08-27 |
Bioarctic Neuroscience Ab |
Improved protofibril selective antibodies and the use thereof
|
US7727525B2
(en)
|
2006-05-11 |
2010-06-01 |
City Of Hope |
Engineered anti-CD20 antibody fragments for in vivo targeting and therapeutics
|
EA200870555A1
(ru)
|
2006-05-19 |
2009-04-28 |
Тева Фармасьютикал Индастриз, Лтд. |
Слитые белки, их применение и способы их получения
|
NZ573818A
(en)
|
2006-06-02 |
2011-09-30 |
Aveo Pharmaceuticals Inc |
Hepatocyte growth factor (hgf) binding proteins
|
RU2487888C2
(ru)
|
2006-06-12 |
2013-07-20 |
ЭМЕРДЖЕНТ ПРОДАКТ ДИВЕЛОПМЕНТ СИЭТЛ, ЭлЭлСи |
Одноцепочечные мультивалентные связывающие белки с эффекторной функцией
|
WO2007146957A2
(en)
|
2006-06-13 |
2007-12-21 |
Irm Llc |
Ror1 as a therapeutic target for lung cancer
|
AU2007262666B2
(en)
|
2006-06-22 |
2013-09-12 |
Walter And Eliza Hall Institute Of Medical Research |
Structure of the insulin receptor ectodomain
|
CN101506239B
(zh)
|
2006-07-12 |
2012-07-25 |
株式会社遗传科技 |
抗人α9整联蛋白抗体及其用途
|
US7910702B2
(en)
|
2006-07-28 |
2011-03-22 |
The Governors Of The University Of Alberta |
Recombinant antibodies to sclerotinia antigens
|
JP2009274958A
(ja)
|
2006-08-31 |
2009-11-26 |
Nara Prefecture |
血液凝固第viii因子の活性化を促進する抗体
|
HUE052220T2
(hu)
|
2006-09-08 |
2021-04-28 |
Abbvie Bahamas Ltd |
Interleukin-13 kötõfehérjék
|
NZ601022A
(en)
|
2006-10-12 |
2014-09-26 |
Chugai Pharmaceutical Co Ltd |
Diagnosis and treatment of cancer using anti-ereg antibody
|
JP5386364B2
(ja)
|
2006-12-18 |
2014-01-15 |
ジェネンテック, インコーポレイテッド |
抗Notch3アンタゴニスト抗体とNotch3関連疾患の予防及び治療におけるその使用
|
WO2008076868A2
(en)
|
2006-12-18 |
2008-06-26 |
Abbott Laboratories |
Methods and compositions related to modulation of receptor tyrosine kinase orphan receptor-1 (ror-1)
|
AU2008216495A1
(en)
|
2007-02-09 |
2008-08-21 |
Genentech, Inc. |
Anti-Robo4 antibodies and uses therefor
|
AU2008219972A1
(en)
|
2007-02-27 |
2008-09-04 |
Forerunner Pharma Research Co., Ltd. |
Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient
|
NZ597466A
(en)
|
2007-03-01 |
2013-08-30 |
Symphogen As |
Recombinant anti-epidermal growth factor receptor antibody compositions
|
KR101123487B1
(ko)
|
2007-03-20 |
2012-03-23 |
일라이 릴리 앤드 캄파니 |
항?스클레로스틴 항체
|
CA2685056C
(en)
|
2007-04-23 |
2015-08-25 |
Fred Hutchinson Cancer Research Center |
Negative immunomodulation of immune responses by erp5
|
EP2152750A1
(en)
|
2007-04-23 |
2010-02-17 |
Schering Corporation |
Anti-mdl-1 antibodies
|
US20100129817A1
(en)
|
2007-05-03 |
2010-05-27 |
Regeneron Pharmaceuticals Inc. |
Identifying germline competent embryonic stem cells
|
US8344112B2
(en)
|
2007-07-31 |
2013-01-01 |
Merck Sharp & Dohme Limited |
IGF-1R specific antibodies useful in the detection and diagnosis of cellular proliferative disorders
|
MX2010001684A
(es)
|
2007-08-15 |
2010-04-21 |
Amunix Inc |
Composiciones y metodos para modificar propiedades de polipeptidos biologicamente activos.
|
CA2699944C
(en)
|
2007-09-21 |
2017-11-14 |
The Regents Of The University Of California |
Targeted interferon demonstrates potent apoptotic and anti-tumor activities
|
US8309323B2
(en)
|
2007-11-13 |
2012-11-13 |
Synthetic Genomics, Inc. |
Dimethyloctane as an advanced biofuel
|
EA020886B1
(ru)
|
2007-11-13 |
2015-02-27 |
ТЕВА БИОФАРМАСЬЮТИКАЛЗ ЮЭсЭй, ИНК. |
Гуманизированные антитела против tl1a
|
US8633139B2
(en)
|
2007-12-21 |
2014-01-21 |
Abbvie Biotherapeutics Inc. |
Methods of screening complex protein libraries to identify altered properties
|
AR070141A1
(es)
|
2008-01-23 |
2010-03-17 |
Glenmark Pharmaceuticals Sa |
Anticuerpos humanizados especificos para el factor von willebrand
|
BRPI0908553A2
(pt)
|
2008-02-28 |
2019-09-24 |
Battelle Energy Alliance Llc |
genes e enzimas termofílicos e termoacidofílicos do metabolismo do alicyclobacillus acidocaldarius, organismos relacionados e métodos
|
WO2009111183A1
(en)
|
2008-03-03 |
2009-09-11 |
Glycofi, Inc. |
Surface display of recombinant proteins in lower eukaryotes
|
US8357782B2
(en)
|
2008-03-21 |
2013-01-22 |
Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo |
Monoclonal antibodies specific for human interferon-alpha subtype alpha 8
|
AR070844A1
(es)
|
2008-03-27 |
2010-05-05 |
Lilly Co Eli |
Fragmento fab o anticuerpo monoclonal humanizado que comprende el fragmento fab, y su uso para la manufactura de un medicamento antagonista del polipeptido del receptor de glucagon para el tratamiento o prevencion de diabetes de tipo 1 o 2
|
EP3002299A1
(en)
|
2008-06-03 |
2016-04-06 |
AbbVie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
JP2010014691A
(ja)
|
2008-06-20 |
2010-01-21 |
Igaku Seibutsugaku Kenkyusho:Kk |
腹水中のメソテリン及び/又は巨核球増強因子を検出するための方法、キット、試薬及び装置
|
MX2010014574A
(es)
|
2008-07-08 |
2011-04-27 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual para prostaglandina e2 y usos de las mismas.
|
US8710022B2
(en)
|
2008-07-18 |
2014-04-29 |
National University Corporation Nagoya University |
Cell proliferation inhibitor
|
WO2010011697A1
(en)
|
2008-07-21 |
2010-01-28 |
Immunomedics Inc. |
Structural variants of antibodies for improved therapeutic characteristics
|
TW201018482A
(en)
|
2008-08-08 |
2010-05-16 |
Glaxo Wellcome Mfg Pte Ltd |
Novel treatment
|
BR122021014165B1
(pt)
|
2008-08-18 |
2022-08-16 |
Evogene Ltd. |
Método para aumentar a eficiência de uso do nitrogênio, eficiência de uso de fertilizantes, produção, biomassa e/ou tolerância ao estresse por deficiência de nitrogênio e seca de uma planta, e, construção de ácido nucleico isolado
|
NZ592436A
(en)
|
2008-11-06 |
2012-10-26 |
Glenmark Pharmaceuticals Sa |
Treatment with anti-alpha2 integrin antibodies
|
US8383778B2
(en)
|
2009-01-29 |
2013-02-26 |
Abbvie Inc. |
IL-1 binding proteins
|
EP2772269A3
(en)
|
2009-03-05 |
2015-01-14 |
Abbvie Inc. |
IL-17 binding proteins
|
AU2010238723A1
(en)
|
2009-04-23 |
2011-11-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-human ROR1 antibodies
|
EP2246364A1
(en)
|
2009-04-29 |
2010-11-03 |
Pierre Fabre Médicament |
Anti CXCR4 antibodies for the treatment of HIV
|
US8753631B2
(en)
|
2009-05-01 |
2014-06-17 |
New York University |
Therapeutic agents for inducing platelet fragmentation and treating thromboembolic disorders
|
WO2010138184A2
(en)
|
2009-05-27 |
2010-12-02 |
Synageva Biopharma Corp. |
Avian derived antibodies
|
US8858949B2
(en)
|
2009-08-06 |
2014-10-14 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
PE20121530A1
(es)
|
2009-09-01 |
2012-12-22 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual
|
EP2473530B1
(en)
|
2009-09-03 |
2015-04-22 |
Vancouver Biotech Ltd. |
Monoclonal antibodies against gonadotropin-releasing hormone receptor
|
CA2774260C
(en)
|
2009-09-16 |
2018-10-09 |
Immunomedics, Inc. |
Class i anti-cea antibodies and uses thereof
|
DE102009045006A1
(de)
|
2009-09-25 |
2011-04-14 |
Technische Universität Dresden |
Anti-CD33 Antikörper und ihre Anwendung zum Immunotargeting bei der Behandlung von CD33-assoziierten Erkrankungen
|
CN102753580A
(zh)
|
2009-10-28 |
2012-10-24 |
亚培生物医疗股份有限公司 |
抗egfr抗体及其用途
|
US20120282177A1
(en)
|
2009-11-02 |
2012-11-08 |
Christian Rohlff |
ROR1 as Therapeutic and Diagnostic Target
|
CN102712695B
(zh)
|
2009-12-18 |
2015-01-21 |
堪瑟拉公司 |
能够诱导细胞死亡的ror1生物抑制剂
|
EP2338486A1
(en)
|
2009-12-18 |
2011-06-29 |
Johannes Gutenberg-Universität Mainz |
3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives for use in the treatment of colon and gastric adenocarcinoma
|
TW201132759A
(en)
|
2009-12-18 |
2011-10-01 |
Sanofi Aventis |
Novel antagonist antibodies and their FaB fragments against GPVI and uses thereof
|
TWI513466B
(zh)
|
2010-01-20 |
2015-12-21 |
Boehringer Ingelheim Int |
抗凝血劑解毒劑
|
EP2539446B1
(en)
|
2010-01-25 |
2017-11-01 |
Alere Scarborough Inc. |
A25 bacteriophage lysin
|
PE20121702A1
(es)
|
2010-01-28 |
2012-12-14 |
Glaxo Group Ltd |
Proteinas de enlace cd127
|
US8828398B2
(en)
|
2010-02-04 |
2014-09-09 |
Toray Industries, Inc. |
Pharmaceutical composition for treating and/or preventing cancer
|
BR112012020101A2
(pt)
|
2010-02-11 |
2018-09-25 |
Alexion Pharma Inc |
método diagnósticos e terapêuticos usando anticorpos anti-cd200.
|
RU2015102845A
(ru)
|
2010-02-23 |
2015-06-10 |
Санофи |
АНТИТЕЛА К ИНТЕГРИНУ α2 И ИХ ПРИМЕНЕНИЯ
|
SI2539366T1
(en)
|
2010-02-26 |
2018-05-31 |
Bioarctic Neuroscience Ab |
PROTOTRIBRIL-RELATED APPEALS AND THEIR USE IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR PARKINSON'S DISEASE, DEMONS WITH LEWY BODIES AND OTHER ALPHA-SYNUKLEINOPATHIES
|
ES2638521T5
(es)
|
2010-03-05 |
2021-03-02 |
Univ Johns Hopkins |
Composiciones y métodos para anticuerpos y proteínas de fusión inmunomoduladores dirigidos contra dianas
|
CN102190728B
(zh)
|
2010-03-17 |
2014-07-02 |
永卓博济(上海)生物医药技术有限公司 |
一种人源化抗cd20单克隆抗体
|
US8468130B2
(en)
|
2010-04-02 |
2013-06-18 |
Skyfire Labs, Inc. |
Assisted hybrid mobile browser
|
EP2563393B1
(en)
|
2010-04-26 |
2016-06-08 |
Abraxis BioScience, LLC |
Sparc binding antibodies and uses thereof
|
AU2011245117B2
(en)
|
2010-04-30 |
2015-03-12 |
Alexion Pharmaceuticals, Inc. |
Anti-C5a antibodies and methods for using the antibodies
|
CN101928347B
(zh)
|
2010-05-05 |
2013-03-27 |
上海海抗中医药科技发展有限公司 |
抗癌胚抗原抗体及其应用
|
JP2013530165A
(ja)
|
2010-06-03 |
2013-07-25 |
アブラクシス バイオサイエンス リミテッド ライアビリティー カンパニー |
末梢血sparc結合抗体及びその使用
|
PT2580240T
(pt)
|
2010-06-14 |
2019-03-29 |
Lykera Biomed S A |
Anticorpos as100a4 e utilizações terapêuticas dos mesmos
|
US9242014B2
(en)
|
2010-06-15 |
2016-01-26 |
The Regents Of The University Of California |
Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment conjugates and methods of use thereof
|
US9163258B2
(en)
|
2010-07-23 |
2015-10-20 |
Fred Hutchinson Cancer Research Center |
Method for the treatment of obesity
|
EP2608809B1
(en)
|
2010-08-27 |
2019-05-22 |
Gilead Biologics, Inc. |
Antibodies to matrix metalloproteinase 9
|
DK3327040T3
(da)
|
2010-09-21 |
2021-09-20 |
Altor Bioscience Corp |
Multimeriske opløselige il-15-fusionsmolekyler og fremgangsmåder til at fremstille og anvende samme
|
US9228023B2
(en)
|
2010-10-01 |
2016-01-05 |
Oxford Biotherapeutics Ltd. |
Anti-ROR1 antibodies and methods of use for treatment of cancer
|
RU2013123793A
(ru)
|
2010-11-24 |
2014-12-27 |
Лексикон Фармасьютикалз, Инк. |
Антитела, связывающиеся с notum пектинацетилэстеразой
|
AU2011336650B2
(en)
|
2010-12-01 |
2016-12-08 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric rabbit/human ROR1 antibodies
|
GB201020995D0
(en)
|
2010-12-10 |
2011-01-26 |
Bioinvent Int Ab |
Biological materials and uses thereof
|
US8853365B2
(en)
|
2010-12-21 |
2014-10-07 |
Abbvie Inc. |
Dual variable domain immunnoglobulins and uses thereof
|
CA2858350A1
(en)
|
2011-01-14 |
2013-07-19 |
The Regents Of The University Of California |
Therapeutic antibodies against ror-1 protein and methods for use of same
|
WO2012130834A1
(en)
|
2011-03-30 |
2012-10-04 |
Boehringer Ingelheim International Gmbh |
Anticoagulant antidotes
|
CN107189997A
(zh)
|
2011-04-21 |
2017-09-22 |
洛克菲勒大学 |
用于革兰氏阳性菌检测和治疗的链球菌属细菌噬菌体溶素
|
WO2013019730A1
(en)
|
2011-07-29 |
2013-02-07 |
The Washington University |
Antibodies to tip-1 and grp78
|
EP2742067A4
(en)
|
2011-08-12 |
2015-03-04 |
Omeros Corp |
MONOCLONAL FZD10 ANTIBODIES AND METHOD FOR THEIR USE
|
JP6317670B2
(ja)
|
2011-08-15 |
2018-04-25 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
ブドウ球菌プロテインaに対する抗体に関連した組成物および方法
|
EP2776470A2
(en)
|
2011-11-11 |
2014-09-17 |
Rinat Neuroscience Corporation |
Antibodies specific for trop-2 and their uses
|
KR102038310B1
(ko)
|
2011-11-16 |
2019-11-01 |
베링거 인겔하임 인터내셔날 게엠베하 |
항 il-36r 항체
|
JP2015501639A
(ja)
|
2011-11-23 |
2015-01-19 |
アイジェニカ バイオセラピューティクス インコーポレイテッド |
抗cd98抗体およびその使用方法
|
US10464079B2
(en)
|
2011-11-28 |
2019-11-05 |
Xiamen Solex High-Tech Industries Co., Ltd. |
Concealed top cover-type shower head
|
EP2617319A1
(en)
|
2012-01-17 |
2013-07-24 |
Braun GmbH |
Head portion and handle portion of an oral care device
|
HUE13746964T2
(hu)
|
2012-02-06 |
2020-01-28 |
Inhibrx Inc |
CD47 antitestek és alkalmazási eljárásaik
|
AU2013230484B2
(en)
|
2012-03-03 |
2017-04-27 |
Immungene, Inc. |
Engineered antibody-interferon mutant fusion molecules
|
DK2877576T3
(da)
|
2012-07-24 |
2019-08-12 |
Bp Corp North America Inc |
Xyloseisomeraser og anvendelser deraf
|
CN103792364B
(zh)
|
2012-10-31 |
2016-06-08 |
张宝弘 |
用于检测外周血中循环肿瘤细胞ror1蛋白的试剂及其应用
|
TWI745610B
(zh)
|
2012-11-14 |
2021-11-11 |
美商再生元醫藥公司 |
重組細胞表面捕捉蛋白質
|
EP2970468B1
(en)
|
2013-03-13 |
2021-07-07 |
Novartis AG |
Notch2 binding molecules for treating respiratory diseases
|
MX2015012825A
(es)
|
2013-03-14 |
2016-06-10 |
Abbott Lab |
Anticuerpos monoclonales del dominio de union de lipido del núcleo del virus de la hepatitis c vhc.
|
US9068204B2
(en)
|
2013-03-15 |
2015-06-30 |
The United States Of America, As Represented By The Secretary Of Agriculture |
Peptidoglycan hydrolase antimicrobials for eradicating lactobacilli that contaminate and reduce ethanol yields in biofuel fermentation
|
EP2789630A1
(en)
|
2013-04-09 |
2014-10-15 |
EngMab AG |
Bispecific antibodies against CD3e and ROR1
|
CN112457403B
(zh)
|
2013-09-13 |
2022-11-29 |
广州百济神州生物制药有限公司 |
抗pd1抗体及其作为治疗剂与诊断剂的用途
|
MX2016007654A
(es)
|
2013-12-11 |
2017-08-15 |
Regeneron Pharma |
Metodos y composiciones para la modificacion dirigida de un genoma.
|
BR112016013514B1
(pt)
|
2013-12-13 |
2022-04-19 |
Stora Enso Oyj (Fi) |
Papelão de múltiplas camadas
|
TWI726608B
(zh)
|
2014-07-03 |
2021-05-01 |
英屬開曼群島商百濟神州有限公司 |
抗pd-l1抗體及其作為治療及診斷之用途
|
CA2952315A1
(en)
|
2014-07-11 |
2016-01-14 |
Genentech, Inc. |
Notch pathway inhibition
|